Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

503
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
503
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.0K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathological and duplex characteristics of deep venous stents: A novel microsurgical small animal model.

Vascular medicine (London, England)·2026
Same author

Dynamic Bayesian networks to predict loss of kidney function: a cross-institution use case in a large cohort with or at-risk of CKD.

BMC medical informatics and decision making·2026
Same author

Does the Timing of USMLE Step 1 Affect Performance? A Comparison of Pre- and Post-Clerkship Timing in the Pass/Fail Era.

Teaching and learning in medicine·2026
Same author

In Stent Re-stenosis Biopsy Findings and Stent Failure Risk Factors in Iliofemoral Venous Stenting: Analysis of 151 Biopsy Samples in 84 Patients and Long Term Outcomes.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Feasibility and Form Factor Validation of Reflective Shoulder-Mounted Pulse Oximeter in Patients with Suspected Sleep Apnea.

Sensors (Basel, Switzerland)·2026
Same author

Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS).

Cell death & disease·2026

Related Experiment Video

Updated: Mar 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K

Decline in Cardiovascular Mortality: Possible Causes and Implications.

George A Mensah1, Gina S Wei2, Paul D Sorlie2

  • 1From the Center for Translation Research and Implementation Science (CTRIS) (G.A.M., M.M.E.) and Division of Cardiovascular Sciences (G.S.W., P.D.S., L.J.F., Y.R., P.G.K., M.E.M., L.L.H., E.A., D.G.), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. George.Mensah@nih.gov.

Circulation Research
|January 21, 2017
PubMed
Summary

Cardiovascular disease mortality has significantly declined due to advances in prevention and treatment. However, recent trends suggest this progress may be slowing or reversing in some groups.

Keywords:
cardiovascular diseasescoronary diseasehypertensionmortalityrisk factors

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.6K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.6K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.6K

Area of Science:

  • Cardiovascular epidemiology
  • Public health advancements
  • Medical treatment innovations

Background:

  • Coronary heart disease (CHD) and stroke mortality rates unexpectedly declined in the US starting in the mid-1970s, following decades of increase.
  • A 1978 conference confirmed a significant downtick in CHD and stroke mortality, a trend that became unmistakable globally by 2000.
  • Age-adjusted mortality rates for CHD and stroke decreased to approximately one-third of their 1960s levels by 2000.

Purpose of the Study:

  • To analyze the remarkable decline in cardiovascular disease mortality over the past four decades.
  • To explore the factors contributing to this decline, including prevention and treatment strategies.
  • To address emerging concerns about the potential abatement or reversal of these positive trends.

Main Methods:

  • Review of epidemiological data on cardiovascular disease mortality trends.
  • Analysis of factors influencing mortality, such as smoking cessation, hypertension control, statin use, and acute coronary syndrome treatments.
  • Solicitation of input for a follow-up conference to discuss current and future cardiovascular mortality trends.

Main Results:

  • The decline in CHD and stroke mortality is attributed to progress in prevention (e.g., reduced smoking) and treatment (e.g., hypertension management, statins, thrombolysis, stents).
  • Despite significant advances, questions remain about the sustainability of this decline.
  • Evidence suggests the rate of decline may be slowing and potentially reversing in certain populations.

Conclusions:

  • The decline in cardiovascular mortality represents a major public health success, driven by multifaceted interventions.
  • Continued monitoring and research are crucial to understand and address potential reversals in cardiovascular health trends.
  • A forthcoming conference aims to re-evaluate these trends and inform future public health strategies for cardiovascular disease.